|
|
Dermatology
Research Funding
(listed alphabetically by Principal Investigator)
A Randomized, Split-Face Comparison of the Treatment of Facial Angiofibromas in Tuberous Sclerosis Utilizing a Frequency-Doubled Nd:YAG (KTP) Laser, a 585nm Pulsed-Dye Laser with a 40ms Pulse Duration, and a 585nm Pulsed-Dye Laser with a 0.5ms Pulse Duration
Principal Investigator: Joanna M. Burch, MD
Source: Dermatology Foundation
Amount: $20,000
Term: 2004-2005
Skin Cancer Prevention in a Pediatric Population
Principal Investigator: Lori A. Crane, PhD, MPH
Co-Investigators: Joseph G. Morelli, MD, Stefan T. Mokrohisky, MD, Tim E. Byers, MD, MPH, Anna Baron, PhD, and Robert Dellavalle, MD, PhD
Source: National Cancer Institute - 5 RO1 CA-74592
Amount: $1,463,981
Term: 2003-2007
Training in Immunodermatology
Co-Investigators: David A. Norris, MD, and William L. Weston, MD
Source: National Institutes of Health - T32 AR07411-20
Amount: $583,705
Term: 2002-2006
2003-2004
Molecular Mechanisms in Acanthosis Nigricans
Principal Investigator: Gary A. Bellus, MD, PhD
Source: National Institutes of Health - KO8 AR02075-03
Amount: $517,174
Term: 1999-2004
A Randomized, Split-Face Comparison of the Treatment of Facial Angiofibromas in Tuberous Sclerosis Utilizing a Frequency-Doubled Nd:YAG (KTP) Laser, a 585nm Pulsed-Dye Laser with a 40ms Pulse Duration, and a 585nm Pulsed-Dye Laser with a 0.5ms Pulse Duration
Principal Investigator: Joanna M. Burch, MD
Source: Dermatology Foundation
Amount: $20,000
Term: 2004-2005
A Randomized Double-Blind Study Comparing the S-Caine Peel (Lidocaine 7% and Tetracaine 7%) to EMLA Cream for the Induction of Local Dermal Anesthesia for Pulsed Dye Laser Therapy in Pediatric Subjects
Co-Investigators: Joanna M. Burch, MD, and Joseph G. Morelli, MD
Source: Zars Inc.
Amount: $14,045
Term: 2003
National Neonatal Lupus Registry
Principal Investigator: Jill Buyon, MD
Consultant: William L. Weston, MD
Source: National Institutes of Health, Scientific Advisory Board - N01 AR4220
Term: 1994-2004
A Randomized Double-Blind Study Comparing the S-Caine Peel (Lidocaine 7% and Tetracaine 7%) to EMLA Cream for the Induction of Local Dermal Anesthesia for Pulsed Dye Laser Therapy in Pediatric Subjects
Co-Investigators: Joseph G. Morelli, MD, Stefan T. Mokrohisky, MD, Tim E. Byers, MD, MPH, Anna Baron, PhD, and Robert Dellavalle, MD, PhD
Source: National Cancer Institute - 5 RO1 CA-74592
Amount: $1,463,981
Term: 2003-2007
IGF-1 Apoptotic Defenses in Melanocytes and Vitiligo
Principal Investigator: Joseph G. Morelli, MD
Source: National Institute of Arthritis, Musculoskeletal and Skin Diseases - RO3 AR46400-02
Amount: $226,500
Term: 2000-2003
Training in Immunodermatology
Co-Investigators: David A. Norris, MD, and William L. Weston, MD
Source: National Institutes of Health - T32 AR07411-20
Amount: $583,705
Term: 2002-2006
2001-2002
Genetic Heterogeneity and Therapy Potential in Hypochondroplasia
Principal Investigator: Art Aylsworth, MD
Co-Investigators: Gary A. Bellus, MD, PhD, Susan Blanton, MD, and Thaddeus Kelly, MD, PhD
Source: Genetech Foundation for Growth and Development - UNIVNC5-49841
Amount: $56,250
Term: 1999-2002
Molecular Mechanisms in Acanthosis Nigricans
Principal Investigator: Gary A. Bellus, MD, PhD
Source: National Institutes of Health - KO8 AR02075-03
Amount: $517,174
Term: 1999-2004
National Neonatal Lupus Registry
Principal Investigator: Jill Buyon, MD
Consultant: William L. Weston, MD
Source: National Institutes of Health, Scientific Advisory Board - N01 AR4220
Term: 1994-2004
Skin Cancer Prevention in a Pediatric Population
Principal Investigator: Lori A. Crane, PhD, MPH
Co-Investigators: Joseph G. Morelli, MD, Tim E. Byers, MD, MPH, James R. Murphy, PhD, Stefan T. Mokrohisky, MD, and Joseph J. Yohn, MD
Source: National Cancer Institute - 5 RO1 CA744592-04
Amount: $735,945
Term: 1997-2001
IGF-1 Apoptotic Defenses in Melanocytes and Vitiligo
Principal Investigator: Joseph G. Morelli, MD
Source: National Institute of Arthritis, Musculoskeletal and Skin Diseases - RO3 AR46400-02
Amount: $226,500
Term: 2000-2003
Training in Immunodermatology
Co-Investigators: David A. Norris, MD, and William L. Weston, MD
Source: National Institutes of Health - T32 AR07411-20
Amount: $583,705
Term: 2002-2006
1999-2000
Genetic Heterogeneity and Therapy Potential in Hypochondroplasia
Principal Investigator: Art Aylsworth, MD
Co-Investigators: Gary A. Bellus, MD, PhD, Susan Blanton, MD, and Thaddeus Kelly, MD, PhD
Source: Genetech Foundation for Growth and Development
Amount: $56,250
Term: January 1999-December 2002
Molecular Mechanisms in Acanthosis Nigricans
Principal Investigator: Gary A. Bellus, MD, PhD
Source: National Institutes of Health
Amount: $517,174
Term: May 1999-April 2004
National Neonatal Lupus Registry
Principal Investigator: Jill Buyon, MD
Consultant: William L. Weston, MD
Source: Scientific Advisory Board
Term: November 1994-October 2004
Skin Cancer Prevention in a Pediatric Population
Principal Investigator: Lori A. Crane, PhD, MPH
Co-Investigators: Joseph G. Morelli, MD, Tim E. Byers, MD, MPH, James R. Murphy, PhD, Stefan T. Mokrohisky, MD, and Joseph J. Yohn, MD
Source: National Cancer Institute
Amount: $735,945
Term: June 1997-June 2001
IGF-1 Apoptotic Defenses in Melanocytes and Vitiligo
Principal Investigator: Joseph G. Morelli, MD
Source: National Institute of Arthritis, Musculoskeletal and Skin Diseases
Amount: $226,500
Term: June 2000-May 2003
Training in Immunodermatology
Principal Investigator: William L. Weston, MD
Source: National Institutes of Health
Amount: $583,705
Term: May 1996-April 2001
|
|
